Search filters

List of works by Michael Szarek

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

article

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

scientific article published in 2022

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

scientific article published on 01 July 2019

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

scientific article published on 01 September 2019

Estimation of overall survival in an ‘illness–death’ model with application to the vertical transmission of HIV‐1 ⬇️

scientific article published on August 30, 2010

High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial

scientific article published on 7 September 2004

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

scientific article published on 3 August 2021

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

scientific article published on 14 October 2020

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

scientific article published in May 2021

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo

scientific article

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

scientific article published on 16 November 2020

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

scientific article published on 16 November 2020

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels

scientific article published on 06 October 2021

Paulina is supported by:

About Paulina

Help